주식 가격. PHST - 주식 시세, 차트, 과거 거래, 주식 채팅, 재무.

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

프리미엄

가격

5.48

매수가

0.00

매도가

0.00

거래량

0.00 일간 변동폭 0.00

0.00 52주 범위 0.00

전일 종가

5.48

개장가

최근 거래 시간

마지막 거래 시간

평균 볼륨(3m)

재정 규모

VWAP

Pharsight Launches PK Accelerator(TM)

PK Accelerator Bundled Solution Accelerates Pharmacokinetic Analysis and Reporting MOUNTAIN VIEW, Calif., June 24 /PRNewswire-FirstCall/...

Pharsight to Present on IVIVC at Bioequivalence & Bioavailability Strategies Conference

Talk Will Cover the Use of Pharsight Software for In-Vitro / In-Vivo Correlation Modeling in Drug Development MOUNTAIN VIEW, Calif., June 23...

Pharsight to Present on Literature-Based Disease Modeling Approaches at AAPS National Biotechnology Conference

Dr. Farkad Ezzet Will Present on the Strategic Value of Literature Modeling to Assess Disease Progression and Drug Attributes in Clinical...

Pharsight to Present on Oncology Modeling and Simulation at PAGE Annual Meeting

Dr. Laurent Claret Will Present Case Studies on the Value of Drug-Disease Modeling to Predict Efficacy and Survival Benefits of Anticancer Agents...

Pharsight to Present on Its Vision for Modeling and Simulation Software at PAGE Annual Meeting

Dr. Robert Leary Will Discuss Computational Methods for Model Evaluation; Dr. Mike Dunlavey Will Present Simplified Programming Approaches of...

Pharsight Invited to Present on Modeling and Simulation at ARCS Australia Scientific Congress

Dr. Helen Kastrissios Will Present on Communicating the Value of Pharmacodynamic Modeling in Clinical Drug Development MOUNTAIN VIEW, Calif., May...

Pharsight Hosts European PKS User Meeting

Second Annual European Meeting to be Held In Paris MOUNTAIN VIEW, Calif., May 23 /PRNewswire-FirstCall/ -- Pharsight Corporation (NASDAQ:PHST...

Pharsight Achieves $7.6 Million In Quarterly Revenue

Fourth Quarter Revenue Highest in Company History; Full Year Revenue Up 13% MOUNTAIN VIEW, Calif., May 8 /PRNewswire-FirstCall/ -- Pharsight...

Pharsight Invited to Present on Antiviral Modeling and Simulation at DIA Adherence Workshop

Dr. Bill Poland Will Present on the Strategic Use of Incorporating Adherence Data into Clinical Trial Predictions of Antiviral Therapies MOUNTAIN...

Pharsight Strengthens Senior Management Team

John Murphy Appointed as New Senior Vice President of Consulting Services MOUNTAIN VIEW, Calif., April 29 /PRNewswire-FirstCall/ -- Pharsight...

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

PHST - Frequently Asked Questions (FAQ)

What is the current share price?

The current share price of is US$ 5.48

What is the 1 year trading range for share price?

has traded in the range of US$ 0.00 to US$ 0.00 during the past year

가장 활성
% 상승자
% 패자

기호	가격	볼륨
MSPRMSP Recovery Inc	US$ 2.86 (123.44%)	25.87M
BONBon Natural Life Ltd	US$ 0.1084 (78.58%)	88.18M
TURN180 Degree Capital Corporation	US$ 5.71 (56.87%)	2
AIPArteris Inc	US$ 8.99 (48.84%)	6
TKNOAlpha Teknova Inc	US$ 7.99 (47.69%)	1
EFSIEagle Financial Services Inc	US$ 11.01 (-63.72%)	28
ALTIAITi Global Inc	US$ 1.20 (-57.30%)	209
FNWBFirst Northwest Bancorp	US$ 5.00 (-50.20%)	155
CEADCEA Industries Inc	US$ 5.20 (-40.84%)	7
PHLTPerformant Healthcare Inc	US$ 1.50 (-38.02%)	208
STSSSharps Technology Inc	US$ 0.0257 (40.44%)	184.77M
LGMKLogicMark Inc	US$ 0.0093 (-1.06%)	91.64M
DMNDamon Inc	US$ 0.0041 (-2.38%)	90.38M
BONBon Natural Life Ltd	US$ 0.1084 (78.58%)	88.18M
MSPRMSP Recovery Inc	US$ 2.86 (123.44%)	25.87M

게시물을 찾을 수 없습니다

시장 데이터

뉴스

도구

시장

팔로우

Hot Features

피드 팔로우

실시간 옵션 플로우

모니터

Pharsight Corp (MM) (PHST)

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

주요 통계 및 세부정보

PHST 최신 뉴스

Pharsight Launches PK Accelerator(TM)

Pharsight to Present on IVIVC at Bioequivalence & Bioavailability Strategies Conference

Pharsight to Present on Literature-Based Disease Modeling Approaches at AAPS National Biotechnology Conference

Pharsight to Present on Oncology Modeling and Simulation at PAGE Annual Meeting

Pharsight to Present on Its Vision for Modeling and Simulation Software at PAGE Annual Meeting

Pharsight Invited to Present on Modeling and Simulation at ARCS Australia Scientific Congress

Pharsight Hosts European PKS User Meeting

Pharsight Achieves $7.6 Million In Quarterly Revenue

Pharsight Invited to Present on Antiviral Modeling and Simulation at DIA Adherence Workshop

Pharsight Strengthens Senior Management Team

PHST - Frequently Asked Questions (FAQ)

이동자

PHST Discussion

최근 히스토리

회사 소개

사업

Popular

앱 받기

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

시장 데이터

뉴스

도구

시장

팔로우

Hot Features

피드 팔로우

실시간 옵션 플로우

모니터

Pharsight Corp (MM) (PHST) 시세

Pharsight Corp (MM) (PHST)

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

주요 통계 및 세부정보

PHST 최신 뉴스

Pharsight Launches PK Accelerator(TM)

Pharsight to Present on IVIVC at Bioequivalence & Bioavailability Strategies Conference

Pharsight to Present on Literature-Based Disease Modeling Approaches at AAPS National Biotechnology Conference

Pharsight to Present on Oncology Modeling and Simulation at PAGE Annual Meeting

Pharsight to Present on Its Vision for Modeling and Simulation Software at PAGE Annual Meeting

Pharsight Invited to Present on Modeling and Simulation at ARCS Australia Scientific Congress

Pharsight Hosts European PKS User Meeting

Pharsight Achieves $7.6 Million In Quarterly Revenue

Pharsight Invited to Present on Antiviral Modeling and Simulation at DIA Adherence Workshop

Pharsight Strengthens Senior Management Team

PHST - Frequently Asked Questions (FAQ)

이동자

PHST Discussion

최근 히스토리

회사 소개

사업

Popular

앱 받기

광고 제거

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS